Overexpression of PPARγ can down-regulate Skp2 expression in MDA-MB-231 breast tumor cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overexpression of PPARγ can down-regulate Skp2 expression in MDA-MB-231 breast tumor cells

Published:2010-08-24 Issue:1-2 Volume:345 Page:171-180
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Meng Jie,Ding Yun,Shen Aiguo,Yan Meijuan,He Fei,Ji Huoyan,Zou Lin,Liu Yonghua,Wang You,Lu Xiaowei,Wang Huimin

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11010-010-0570-y.pdf

Reference26 articles.

1. Hortobagyi GN (1998) Treatment of breast cancer. N Engl J Med 339:974–984

2. Baselga J, Norton L (2002) Focus on breast cancer. Cancer Cell 1:319–322

3. Mangelsdorf DJ, Thummel C, Beato M et al (1995) The nuclear receptor superfamily: the second decade. Cell 83:835–839

4. Kliewer SA, Forman BM, Blumberg B et al (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355–7359

5. Schoonjans K, Staels B, Auwerx J (1996) The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93–109

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skp2: A critical molecule for ubiquitination and its role in cancer;Life Sciences;2024-02

2. Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2;Cancers;2022-06-09

3. Elevated expression of SKP2 correlates with poor prognosis in osteosarcoma: a bioinformatics analysis;Biomedical Research and Therapy;2021-12-31

4. The Skp2 Pathway: A Critical Target for Cancer Therapy;Seminars in Cancer Biology;2020-12

5. PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma;PPAR Research;2020-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3